Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Joe Keegan
AddedMar 31, 2024
UpdatedMay 1, 2026
Joe Keegan

Joe Keegan

Board Member, Interpace Biosciences

Joe Keegan's Career

Interpace Biosciences
Interpace Biosciences

Parsippany-Troy Hills, NJ, US

Board Member· Board
Courtagen Life Sciences
Courtagen Life Sciences

Woburn, MA, US

Board Member· Board
Carterra
Carterra

Salt Lake City, UT, US

Board Member· Board
Unchained Labs
Unchained Labs

Pleasanton, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Joe Keegan's Career

Interpace Biosciences
Interpace Biosciences
Public1471998Parsippany-Troy Hills, NJ, US
Board Member· Board

Leadership at Interpace Biosciences

Tom BurnellTom BurnellCEO
Robert GormanRobert GormanBoard Member
Stephen J. SullivanStephen J. SullivanBoard Member

Similar to Interpace Biosciences

PrecipioPrecipioNew Haven, CT, USCancer Diagnosticsest. 2011PrecipioNew Haven, CT, US · est. 2011

Precipio: A leading cancer diagnostics lab, providing expert advice for optimal patient care.

Public · $3.3M68
BiodesixBiodesixBoulder, CO, USDiagnostic Testsest. 2005BiodesixBoulder, CO, US · est. 2005

Biodesix, Inc.: A leading biotech firm providing data-driven diagnostic solutions and lab tests in the US.

Public · $390.3M245
IES DiagnosticsIES DiagnosticsWayne, PA, USDiagnostic Testsest. 2014IES DiagnosticsWayne, PA, US · est. 2014

IES Diagnostics: Rapid, accurate molecular diagnostic tests using proprietary technology, based in Pennsylvania.

Seed · $140k6
Accelerated Medical DiagnosticsAccelerated Medical DiagnosticsDavis, CA, USCancer Testsest. 2008Accelerated Medical DiagnosticsDavis, CA, US · est. 2008

Accelerated Medical Diagnostics, founded in 2008, develops reliable cancer tests to enhance patient care.

Angel · $50k6
Courtagen Life Sciences
Courtagen Life Sciences
Acquired$65M01999Woburn, MA, US
Board Member· Board

Leadership at Courtagen Life Sciences

Rich UptonRich UptonBoard Member
Brendan McKernanBrendan McKernanFounder
Thomas L Fairfield \"Tom\"Thomas L Fairfield \"Tom\"Board Member

Similar to Courtagen Life Sciences

CasTag BiosciencesCasTag BiosciencesDurham, NC, USBiotechnology, Cell Therapiesest. 2020CasTag BiosciencesDurham, NC, US · est. 2020

CasTag Biosciences: Innovating regenerative medicine and cell biology for faster scientific discovery.

Angel · $280.7k2
Cogent BiosciencesCogent BiosciencesWaltham, MA, USBiotech, Therapiesest. 2014Cogent BiosciencesWaltham, MA, US · est. 2014

US-based Cogent Biosciences develops biotech solutions for genetically driven diseases.

Public · $692.7M138
GeneicdGeneicdScottsdale, AZ, USBiotechnology, Genomicsest. 2019GeneicdScottsdale, AZ, US · est. 2019

GENEICD: A leading biotech firm innovating in genomics for improved patient health.

Seed · $152.5k7
Intact GenomicsIntact GenomicsSt. Louis, MO, USLife Science Productsest. 2013Intact GenomicsSt. Louis, MO, US · est. 2013

St. Louis-based Intact Genomics offers premium life science products and DNA fragment cloning services.

Seed · $4.4M7
Carterra
Carterra
Series A$38.1M932005Salt Lake City, UT, US
Board Member· Board

Recent news

AI comes to software reviews as Stackfix raises $3MTechCrunch · 2024

Leadership at Carterra

James SmithJames SmithFounder
Josh EckmanJosh EckmanCEO

Similar to Carterra

ArrayitArrayitSunnyvale, CA, USMicroarraysest. 1993ArrayitSunnyvale, CA, US · est. 1993

Arrayit Corporation: A biotech firm innovating in genetic analysis and diagnostics for research and healthcare sectors.

Public · $1M7
SpectrafluidicsSpectrafluidicsGoleta, CA, USLaboratory Instrumentsest. 2007SpectrafluidicsGoleta, CA, US · est. 2007

Spectrafluidics, Inc.: US-based manufacturer and commercializer of microfluidics and Raman technology.

Pre-Seed · $2.5M5
FluidigmFluidigmSouth San Francisco, CA, USBiotechnologyest. 1999FluidigmSouth San Francisco, CA, US · est. 1999

Standard BioTools Inc., based in South San Francisco, accelerates life sciences research with essential, standardized technologies.

Public615
ClickbioClickbioReno, NV, USLab Suppliesest. 2015ClickbioReno, NV, US · est. 2015

Empowering scientists with innovative lab supplies and tools for maximum potential.

Seed · $575k9
Unchained Labs
Unchained Labs
Late Stage Private$285M2002015Pleasanton, CA, US
Board Member· Board

Leadership at Unchained Labs

Tim HarknessTim HarknessFounder & CEO
Laura HamillLaura HamillBoard Member
Heather PrestonHeather PrestonBoard Member
Martin MadausMartin MadausBoard Member

Joe Keegan's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Joe Keegan

John PatienceJohn PatienceBoard Member · BiodesixJeremy WilsonJeremy WilsonBoard Member · NowdiagnosticsBill YoungBill YoungBoard Member · Theravance BiopharmaPeter J ConnollyPeter J ConnollyBoard Member · CareCentrixGreg MaddenGreg MaddenBoard Member · AlloCureDennis DrislaneDennis DrislaneBoard Member · NavaDerm